Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MALACHITE-II: Viekira Pak vs Telaprevir in HCV GT1
NCT01854528Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Viekira Pak in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Jun 2013; status: completed.
02
Drugs
Viekira Pak
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01854528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854528.